Page last updated: 2024-11-02

pargyline and Coronary Occlusion

pargyline has been researched along with Coronary Occlusion in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
" Using microdialysis technique in anesthetized rats, we monitored myocardial interstitial levels of 5-HT and its metabolite produced by monoamine oxidase (MAO), 5-hydroxyindole acetic acid (5-HIAA), during 30-min coronary occlusion followed by 45-min reperfusion, and investigated the effects of local administration of the MAO inhibitor pargyline and the 5-HT uptake inhibitor fluoxetine."3.85Myocardial interstitial levels of serotonin and its major metabolite 5-hydroxyindole acetic acid during ischemia-reperfusion. ( Akiyama, T; Du, CK; Inagaki, T; Pearson, JT; Shirai, M; Shishido, T; Zhan, DY, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, CK1
Zhan, DY1
Akiyama, T1
Inagaki, T1
Shishido, T1
Shirai, M1
Pearson, JT1

Other Studies

1 other study available for pargyline and Coronary Occlusion

ArticleYear
Myocardial interstitial levels of serotonin and its major metabolite 5-hydroxyindole acetic acid during ischemia-reperfusion.
    American journal of physiology. Heart and circulatory physiology, 2017, Jan-01, Volume: 312, Issue:1

    Topics: Animals; Coronary Occlusion; Fluoxetine; Hydroxyindoleacetic Acid; Male; Microdialysis; Monoamine Ox

2017